Publications for Lucia Ahlberg
Co-author map based on ISI articles 2007-
Journal Articles
Piotr Kozlowski, Maria Astrom, Lucia Ahlberg, Per Bernell, Erik Hulegardh, Hans Hagglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr and Helene Hallbook
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007
Haematologica, 2012, 97(9), 1414-1421.
|
Peter Gimsing, Kristina Carlson, Ingemar Turesson, Peter Fayers, Anders Waage, Annette Vangsted, Anne Mylin, Christian Gluud, Gunnar Juliusson, Henrik Gregersen, Henrik Hjorth-Hansen, Ingerid Nesthus, Inger Marie S Dahl, Jan Westin, Johan Lanng Nielsen, Lene Meldgaard Knudsen, Lucia Ahlberg, Martin Hjorth, Niels Abildgaard, Niels Frost Andersen, Olle Linder and Finn Wisloeff
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
LANCET ONCOLOGY, 2010, 11(10), 973-982.
Web of Science® Times Cited: 13 |
Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg, Bo Bjorkstrand, Kristina Carlson, Inger Marie Dahl, Karin Forsberg, Nina Gulbrandsen, Einar Haukas, Oyvind Hjertner, Martin Hjorth, Torbjorn Karlsson, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Olle Linder, Ulf-Henrik Mellqvist, Ingerid Nesthus, Jurgen Rolke, Maria Strandberg, Finn Wisloff, Gunnar Juliusson and Ingemar Turesson
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
BLOOD, 2010, 116(9), 1405-1412.
Web of Science® Times Cited: 63 |
M Hedenus, G Birgegård, P Näsman, Lucia Ahlberg, T Karlsson, B Lauri, J Lundin, G Lärfars and A Österborg
Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: A randomized multicenter study
Leukemia, 2007, 21(4), 627-632.
|
Stig Lenhoff, Martin Hjorth, Ingemar Turesson, Jan Westin, Peter Gimsing, Finn Wisloff, Lucia Ahlberg, Kristina Carlson, Ilse Christiansen, Inger Marie Dahl, Karin Forsberg, Lorentz Brinch, Jens Hammerstrom, Hans E. Johnsen and Lene Me Knudsen
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
Haematologica, 2006, 91(9), 1228-1233.
Web of Science® Times Cited: 27 |
C Crawley, M Lalancette, R Szydlo, M Gilleece, K Peggs, S Mackinnon, Gunnar Juliusson, Lucia Ahlberg, A Nagler, A Shimoni, A Sureda, JM Boiron, H Einsele, R Chopra, A Carella, J Cavenagh, A Gratwohl, F Garban, A Zander and B Bjorkstrand
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
Blood, 2005, 105(11), 4532-4539.
Web of Science® Times Cited: 132 |
Conference Articles
Meletios A Dimopoulos, Hadewijch M De Samblanx, Maria G Roussou, Konstantinos Zervas, Eirini Katodritou, Deniz Sargin, Cyrille Hulin, Lucia Ahlberg, Javier De La Rubia, Rita Ganguly, Joris K Diels, Helgi van de Velde, Ravinder Dhawan, Michael D Spencer and Michel Delforge
Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Mono therapy In Patients with Relapsed/Refractory Multiple Myeloma An Interim Report from an International Electronic Observational Study
BLOOD vol 116, issue 21 (ISSN 0006-4971), 2010.
|
S Rosengren, Lucia Ahlberg, K Forsberg, S Lenhoff, U Mellqvist, H Nahi and K Carlson
OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL-AMYLOIDOSIS IN SWEDEN in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 95, issue , pp 393-393
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010.
|
Ulf-Henrik Mellqvist, Jan Westin, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukas, Olle Linder, Hareth Nahi, Ingerid Nesthus, Nilsaage Toffner-Clausen, Raija Silvennoinen, Niels Frost Andersen, Ingemar Turesson and Anders Waage
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial in BLOOD, vol 114, issue 22, pp 221-221
BLOOD, 2009.
Web of Science® Times Cited: 3
|
K. Zervas, E. Katodritou, M. Delforge, H. de Samblanx, D. Sargin, C. Hulin, Lucia Ahlberg, J. de la Rubia, K. Abdulkadyrov, R. Ganguly, J. Diels and R. Dhawan
PATIENT RESPONSE TO BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: INTERIM RESULTS FROM AN OBSERVATIONAL STUDY
in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 94, 2009.
|
M. Delforge, H. de Samblanx, K. Zervas, E. Katodritou, D. Sargin, C. Hulin, Lucia Ahlberg, J. de la Rubia, K. Abdulkadyrov, R. Ganguly, J. Diels and R. Dhawan
SURVIVAL ANALYSIS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: AN INTERIM REPORT FROM AN INTERNATIONAL ELECTRONIC OBSERVATIONAL STUDY OF BORTEZOMIB
in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 94, 2009.
|
Ph.D., Lic. Theses
